|
BCL9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.78129996600774E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.40687503050685E-12 |
| Normal-vs-Stage2 |
1.54086999999414E-05 |
| Normal-vs-Stage3 |
2.755300E-03 |
| Normal-vs-Stage4 |
1.522970E-01 |
| Stage1-vs-Stage2 |
7.100800E-01 |
| Stage1-vs-Stage3 |
6.726100E-02 |
| Stage1-vs-Stage4 |
1.683180E-01 |
| Stage2-vs-Stage3 |
2.560200E-01 |
| Stage2-vs-Stage4 |
2.042000E-01 |
| Stage3-vs-Stage4 |
6.968400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.21789997268252E-09 |
| Normal-vs-AfricanAmerican |
2.86739998411889E-09 |
| Normal-vs-Asian |
2.196600E-03 |
| Caucasian-vs-AfricanAmerican |
8.271000E-01 |
| Caucasian-vs-Asian |
9.751800E-01 |
| AfricanAmerican-vs-Asian |
8.998600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6242562850266E-12 |
| Normal-vs-Female |
4.656000E-03 |
| Male-vs-Female |
4.43969999996963E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.41229999994774E-06 |
| Normal-vs-Extreme_Weight |
3.29136717880374E-12 |
| Normal-vs-Obese |
1.86521999999689E-05 |
| Normal-vs-Extreme_Obese |
9.52019996169895E-09 |
| Normal_Weight-vs-Extreme_Weight |
4.757900E-02 |
| Normal_Weight-vs-Obese |
7.121800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.684300E-02 |
| Extreme_Weight-vs-Obese |
1.181760E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.546200E-01 |
| Obese-vs-Extreme_Obese |
3.663800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.039000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.15570000014387E-07 |
| Normal-vs-Age(61-80Yrs) |
3.46989104116346E-12 |
| Normal-vs-Age(81-100Yrs) |
6.71850000077967E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.941800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.022300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.356900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.994400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.487860E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.399000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62936331093988E-12 |
| Normal-VS-Type2 PRCC |
2.13769999479752E-08 |
| Normal-VS-KIRP CIMP |
5.593000E-01 |
| Normal-VS-Unclassified PRCC |
4.25239999990445E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.213590E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.018070E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.939500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.997880E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.059000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.391600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.27964305818296E-12 |
| Normal-vs-N1 |
4.903600E-01 |
| Normal-vs-N2 |
9.603600E-01 |
| N0-vs-N1 |
1.799180E-03 |
| N0-vs-N2 |
2.107200E-01 |
| N1-vs-N2 |
8.188800E-01 |
|
|
